Clinical Trial Update: ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ertugliflozin in adults with type 2 diabetes and heart failure has been completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Steglatro (ertugliflozin) (ertugliflozin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Type 2 Diabetes Mellitus, Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2025-05-06